FDA Import Refusal AEK-1148817-6/11/1 — AstraZeneca Pharma India Limited
The FDA refused shipment AEK-1148817-6/11/1 from AstraZeneca Pharma India Limited (India) on May 20, 2022. The refused product falls under Drugs and Biologics — METOPROLOL TARTRATE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 20, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY44 METOPROLOL TARTRATE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75